Advertisement

Trends in gestational age at time of surgical abortion for fetal aneuploidy and structural abnormalities

Published:October 27, 2016DOI:https://doi.org/10.1016/j.ajog.2016.10.031

      Background

      Screening for fetal aneuploidy has evolved over the past 2 decades. Whether these advances impact gestational age at abortion has received little study.

      Objective

      We sought to describe trends in the gestational age at the time of abortion by fetal diagnosis over an 11-year study period. We hypothesized that gestational age at time of abortion would decrease for fetal aneuploidy but remain unchanged for structural abnormalities.

      Study Design

      We conducted a retrospective case series of all women undergoing surgical abortion for fetal aneuploidy or structural abnormalities up to 24 weeks’ gestation from 2004 through 2014 in a hospital operating room setting at a single, urban medical center. We excluded labor induction abortions (<1% of abortions at our medical center) and suction aspirations performed in the office practice. We performed suction aspiration up to 14 weeks and dilation and evacuation after that gestational age. We describe the median gestational age at abortion by fetal indication and year.

      Results

      For women undergoing abortion for fetal aneuploidy (n = 392), the median gestational age at time of abortion decreased from 19.0 weeks (interquartile range 18.0-21.0) in 2004 to 14.0 weeks (interquartile range 13.0-17.0) in 2014 (Kruskal-Wallis P < .0001). For women undergoing abortion for fetal structural abnormalities (n = 586), the median gestational age was ≥20 weeks for each year during the study interval (P = .1). As gestational age decreased in the fetal aneuploidy group, fewer women underwent dilation and evacuation and more became eligible for suction aspiration (<14 weeks). In 2004, >90% of women underwent dilation and evacuation for either indication. By 2014, 31% of women with fetal aneuploidy were eligible for suction aspiration compared to 11% of those with structural anomalies.

      Conclusion

      Gestational age at the time of abortion for fetal aneuploidy decreased substantially from 2004 through 2014; earlier abortion is safer for women. In contrast, women seeking abortion for fetal structural abnormalities did not experience a change in timing. Legislation restricting gestational age at the time of abortion could disproportionately affect women with fetal structural abnormalities.

      Key words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Obstetrics & Gynecology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Kerns J.L.
        • Swanson M.
        • Pena S.
        • et al.
        Characteristics of women who undergo second-trimester abortion in the setting of a fetal anomaly.
        Contraception. 2012; 85: 63-68
        • Shaffer B.L.
        • Caughey A.B.
        • Norton M.E.
        Variation in the decision to terminate pregnancy in the setting of fetal aneuploidy.
        Prenat Diagn. 2006; 26: 667-671
        • Crane J.P.
        • LeFevre M.L.
        • Winborn R.C.
        • et al.
        A randomized trial of prenatal ultrasonographic screening: impact on the detection, management, and outcome of anomalous fetuses. The RADIUS Study Group.
        Am J Obstet Gynecol. 1994; 171: 392-399
        • Pryde P.G.
        • Drugan A.
        • Johnson M.
        • Isada N.B.
        • Evans M.I.
        Prenatal diagnosis: choices women make about pursuing testing and acting on abnormal results.
        Clin Obstet Gynecol. 1993; 36: 496-509
        • Natoli J.L.
        • Ackerman D.L.
        • McDermott S.
        • Edwards J.G.
        Prenatal diagnosis of Down syndrome: a systematic review of termination rates (1995-2011).
        Prenat Diagn. 2012; 32: 142-153
        • Malone F.D.
        • Canick J.A.
        • Ball R.H.
        • et al.
        First-trimester or second-trimester screening, or both, for Down's syndrome.
        N Engl J Med. 2005; 353: 2001-2011
        • Lo Y.M.
        • Lun F.M.
        • Chan K.C.
        • et al.
        Digital PCR for the molecular detection of fetal chromosomal aneuploidy.
        Proc Natl Acad Sci U S A. 2007; 104: 13116-13121
        • Jackson L.
        • Wapner R.J.
        Chorionic villus sampling.
        in: Simpson J.L. Elias S. Essentials of prenatal diagnosis. Churchill Livingstone, New York (NY)1993: 45-61
        • American College of Obstetricians and Gynecologists
        Screening for fetal chromosomal abnormalities. ACOG Practice bulletin no. 77.
        Obstet Gynecol. 2007; 109: 217-227
        • American College of Obstetricians and Gynecologists
        Invasive prenatal testing for aneuploidy. ACOG Practice bulletin no. 88.
        Obstet Gynecol. 2007; 110: 1459-1467
        • Hume H.
        • Chasen S.T.
        Trends in timing of prenatal diagnosis and abortion for fetal chromosomal abnormalities.
        Am J Obstet Gynecol. 2015; 213: 545.e1-545.e4
        • Chasen S.T.
        • Kalish R.B.
        Can early ultrasound reduce the gestational age at abortion for fetal anomalies?.
        Contraception. 2013; 87: 63-66
        • ACOG Committee on Obstetric Practice
        Method for estimating due date. Committee opinion no. 611.
        Obstet Gynecol. 2014; 124: 863-866
      1. Guttmacher Institute. State funding of abortion under Medicaid. State policies in brief. Available at: https://www.guttmacher.org/state-policy/explore/state-funding-abortion-under-medicaid. Accessed June 17, 2016.

        • Eleftheriades M.
        • Tsapakis E.
        • Sotiriadis A.
        • Manolakos E.
        • Hassiakos D.
        • Botsis D.
        Detection of congenital heart defects throughout pregnancy; impact of first trimester ultrasound screening for cardiac abnormalities.
        J Matern Fetal Neonatal Med. 2012; 25: 2546-2550
        • Timor-Tritsch I.E.
        • Fuchs K.M.
        • Monteagudo A.
        • D'Alton M.E.
        Performing a fetal anatomy scan at the time of first-trimester screening.
        Obstet Gynecol. 2009; 113: 402-407
        • Jones R.K.
        • Kooistra K.
        Abortion incidence and access to services in the United States, 2008.
        Perspect Sex Reprod Health. 2011; 43: 41-50
        • Zane S.
        • Creanga A.A.
        • Berg C.J.
        • et al.
        Abortion-related mortality in the United States: 1998-2010.
        Obstet Gynecol. 2015; 126: 258-265
        • Upadhyay U.D.
        • Weitz T.A.
        • Jones R.K.
        • Barar R.E.
        • Foster D.G.
        Denial of abortion because of provider gestational age limits in the United States.
        Am J Public Health. 2014; 104: 1687-1694
      2. Guttmacher Institute. State policies on later abortions. State policies in brief. Available at: https://www.guttmacher.org/sites/default/files/state_policy_overview_files/spib_plta.pdf. Accessed June 17, 2016.

        • Pazol K.
        • Creanga A.A.
        • Jamieson D.J.
        Abortion surveillance–United States, 2012.
        MMWR Surveill Summ. 2015; 64: 1-40